Tool to Improve Treatment Adherence and Outcomes at Grady Liver Clinic
| Status: | Completed |
|---|---|
| Conditions: | Hepatitis, Hepatitis |
| Therapuetic Areas: | Immunology / Infectious Diseases |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 2/8/2019 |
| Start Date: | June 5, 2017 |
| End Date: | June 30, 2018 |
Use of a Psychosocial Readiness Tool to Improve Hepatitis C Treatment Adherence and Outcomes at the Grady Liver Clinic
The purpose of this study is to learn more about what psychological and social factors affect
people in how they take their hepatitis C medications.
people in how they take their hepatitis C medications.
The goal of this study is to determine if a qualitative survey that assesses a patient's
readiness for treatment of Hepatitis C (HCV) and associated interventions based on identified
barriers can improve treatment adherence and outcomes. HCV remains a leading cause of liver
cancer and end stage liver disease despite greater than 90% cure rates with new, all-oral
antiviral medications. While these new medications are easier to tolerate and access than
previous treatment regimens, medication adherence still remains a great barrier to cure. In
this study, we will administer the Psychosocial Readiness Evaluation and Preparation for
Hepatitis C Treatment (PREP-C) tool, a free, online survey developed at the Mount Sinai
School of Medicine to determine psychosocial readiness for treatment.
readiness for treatment of Hepatitis C (HCV) and associated interventions based on identified
barriers can improve treatment adherence and outcomes. HCV remains a leading cause of liver
cancer and end stage liver disease despite greater than 90% cure rates with new, all-oral
antiviral medications. While these new medications are easier to tolerate and access than
previous treatment regimens, medication adherence still remains a great barrier to cure. In
this study, we will administer the Psychosocial Readiness Evaluation and Preparation for
Hepatitis C Treatment (PREP-C) tool, a free, online survey developed at the Mount Sinai
School of Medicine to determine psychosocial readiness for treatment.
Inclusion Criteria:
- seen in the Grady Liver Clinic during the study time period
- have a confirmed chronic hepatitis C infection (hepatitis C antibody positive and
detectable hepatitis C viral load)
Exclusion Criteria:
- no chronic hepatitis C infection
- co-infection with HIV or hepatitis B
- non-English speaking
- unable to consent to participate
- already started HCV therapy
We found this trial at
1
site
Click here to add this to my saved trials
